Your browser doesn't support javascript.
loading
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL.
Müller, Kristina; Vogiatzi, Fotini; Winterberg, Dorothee; Rösner, Thies; Lenk, Lennart; Bastian, Lorenz; Gehlert, Carina L; Autenrieb, Marie-Pauline; Brüggemann, Monika; Cario, Gunnar; Schrappe, Martin; Kulozik, Andreas E; Eckert, Cornelia; Bergmann, Anke K; Bornhauser, Beat; Bourquin, Jean-Pierre; Valerius, Thomas; Peipp, Matthias; Kellner, Christian; Schewe, Denis M.
Afiliación
  • Müller K; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Vogiatzi F; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Winterberg D; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Rösner T; Section of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Lenk L; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Bastian L; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Gehlert CL; Section of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Autenrieb MP; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Brüggemann M; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Cario G; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Schrappe M; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Kulozik AE; Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Eckert C; Charité, University Hospital Berlin, Pediatric Hematology/Oncology, Berlin, Germany.
  • Bergmann AK; Institute of Human Genetics, Medical School Hannover, Hannover, Germany.
  • Bornhauser B; Division of Pediatric Oncology, and Children Research Center, University Children's Hospital, Zurich, Switzerland.
  • Bourquin JP; Division of Pediatric Oncology, and Children Research Center, University Children's Hospital, Zurich, Switzerland.
  • Valerius T; Section of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Peipp M; Section of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Kellner C; Division of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Schewe DM; Department of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Blood ; 140(1): 45-57, 2022 07 07.
Article en En | MEDLINE | ID: mdl-35452517

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Alemania